• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Intravenous compared to oral busulfan with cyclophosphamide for autologous hematopoietic cell transplant conditioning for plasma cell myeloma.

作者信息

Mustafa Ali Moaath, Corrigan Donna M, Rybicki Lisa A, Yurch Melissa A, Cherni Kelly, Liu Hien, Dean Robert, Hamilton Betty, Pohlman Brad, Andresen Steven, Kalaycio Matt, Bolwell Brian J, Majhail Navneet S, Sobecks Ronald

机构信息

Internal Medicine, Cleveland Clinic, Cleveland, OH, United States.

Blood and Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States.

出版信息

Hematol Oncol Stem Cell Ther. 2018 Dec;11(4):253-256. doi: 10.1016/j.hemonc.2018.03.006. Epub 2018 Apr 24.

DOI:10.1016/j.hemonc.2018.03.006
PMID:29705567
Abstract
摘要

相似文献

1
Intravenous compared to oral busulfan with cyclophosphamide for autologous hematopoietic cell transplant conditioning for plasma cell myeloma.静脉注射白消安与口服白消安联合环磷酰胺用于浆细胞骨髓瘤自体造血细胞移植预处理的比较
Hematol Oncol Stem Cell Ther. 2018 Dec;11(4):253-256. doi: 10.1016/j.hemonc.2018.03.006. Epub 2018 Apr 24.
2
[Busulfan, cyclophosphamide and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma].白消安、环磷酰胺和依托泊苷作为多发性骨髓瘤自体干细胞移植的预处理方案
Zhonghua Xue Ye Xue Za Zhi. 2013 Apr;34(4):313-6. doi: 10.3760/cma.j.issn.0253-2727.2013.04.014.
3
Reduced-Intensity Conditioning with Busulfan, Fludarabine, and Antithymocyte Globulin for Hematopoietic Cell Transplantation from Unrelated or Haploidentical Family Donors in Patients with Acute Myeloid Leukemia in Remission.使用白消安、氟达拉滨和抗胸腺细胞球蛋白进行减低强度预处理用于缓解期急性髓系白血病患者接受无关或单倍体相合家庭供者造血细胞移植
Biol Blood Marrow Transplant. 2017 Sep;23(9):1555-1566. doi: 10.1016/j.bbmt.2017.05.025. Epub 2017 May 25.
4
Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150).多骨髓瘤患者自体干细胞移植用静脉注射白消安和马法兰预处理方案的 2 期研究（KMM150）。
Biol Blood Marrow Transplant. 2018 May;24(5):923-929. doi: 10.1016/j.bbmt.2018.01.004. Epub 2018 Jan 12.
5
Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma.静脉注射白消安加美法仑与单独使用美法仑作为多发性骨髓瘤患者的预处理方案比较。
Ann Hematol. 2019 Aug;98(8):2013-2015. doi: 10.1007/s00277-019-03663-5. Epub 2019 Mar 16.
6
Haploidentical Stem Cell Transplant With Post Transplant Cyclophosphamide for Chronic Granulomatous Disease With Thiotepa, Busulfan, and Fludarabine as Conditioning.采用硫替派、白消安和氟达拉滨进行预处理，联合移植后环磷酰胺的单倍体相合干细胞移植治疗慢性肉芽肿病
J Pediatr Hematol Oncol. 2021 May 1;43(4):155-156. doi: 10.1097/MPH.0000000000002015.
7
Mortality outcomes after busulfan-containing conditioning treatment and haemopoietic cell transplantation in patients with Gilbert's syndrome: a retrospective cohort study.吉尔伯特综合征患者接受含白消安预处理治疗及造血细胞移植后的死亡率结局：一项回顾性队列研究
Lancet Haematol. 2016 Nov;3(11):e516-e525. doi: 10.1016/S2352-3026(16)30149-1.
8
Thiotepa, busulfan, cyclophosphamide (TBC) and autologous hematopoietic transplantation: an intensive regimen for the treatment of multiple myeloma.噻替派、白消安、环磷酰胺（TBC）与自体造血干细胞移植：一种用于治疗多发性骨髓瘤的强化方案
Bone Marrow Transplant. 2001 Apr;27(8):821-8. doi: 10.1038/sj.bmt.1703007.
9
[A modified myeloablative conditioning regimen for allogeneic hematopoietic stem cell transplantation, consisting of intravenous busulfan, cyclophosphamide and total lymphoid irradiation, in advanced leukemia].[一种用于异基因造血干细胞移植的改良清髓预处理方案，由静脉注射白消安、环磷酰胺和全身淋巴照射组成，用于晚期白血病]
Gan To Kagaku Ryoho. 2010 Sep;37(9):1691-5.
10
Dose modification protocol using intravenous busulfan (Busulfex) and cyclophosphamide followed by autologous or allogeneic peripheral blood stem cell transplantation in patients with hematologic malignancies.在血液系统恶性肿瘤患者中，使用静脉注射白消安（Busulfex）和环磷酰胺，随后进行自体或异基因外周血干细胞移植的剂量调整方案。
Biol Blood Marrow Transplant. 2004 Sep;10(9):614-23. doi: 10.1016/j.bbmt.2004.05.010.